H.‐W. Chang

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Tropospheric ozone over the North Pacific from ozonesonde observations

S. J. Oltmans, B. J. Johnson, Joyce M. Harris et al. · Journal of Geophysical Research Atmospheres · 2004 · 101 citations

Engineering, North Pacific, Atmospheric Photochemistry +18

Restless legs syndrome in end‐stage renal disease: a multicenter study in <scp>T</scp>aiwan

Chin‐Hsien Lin, Vin‐Cent Wu, Wenya Li et al. · European Journal of Neurology · 2013 · 61 citations

Factors predictive of fatality in massive middle cerebral artery territory infarction and clinical experience of decompressive hemicraniectomy

K.‐W. Wang, Wen‐Cheng Chang, Ji‐Chen Ho et al. · European Journal of Neurology · 2006 · 51 citations

Cerebrovascular Disease, Decompressive Hemicraniectomy, Clinical Experience +21